Acute Lymphocytic Leukemia (ALL) Recruiting Phase 2 Trials for Cyclophosphamide (DB00531)

Also known as: Lymphocytic Leukemia, Acute / Acute Lymphocytic Leukemia / Acute Lymphoid Leukemia (ALL) / Acute Lymphatic Leukemia / Acute Lymphocytic Leukaemia / Acute Lymphoid Leukemia / Acute lymphoblastic leukemia with failed remission / Acute lymphoblastic leukaemia / Leukemia lymphoblastic acute / Acute lymphoblastic leukemia / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / ALL / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic

IndicationStatusPhase
DBCOND0030518 (Acute Lymphocytic Leukemia (ALL))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02605460Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete RemissionTreatment
NCT03615105Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsTreatment
NCT02661035Allo HSCT Using RIC for Hematological DiseasesTreatment
NCT02581007RIC Transplant Using Haplo DonorsTreatment
NCT02861417Timed Sequential Busulfan and Post Transplant Cyclophosphamide for Allogeneic TransplantationTreatment
NCT03088709Haploidentical Stem Cell Transplantation Using Post-Transplant CyclophosphamidePrevention
NCT02043587Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic LymphomaTreatment